BSE filing, NSE: DENISCHEM. Summary written from the filing by ALFA Finder's alert engine.
Denis Chem Lab Ltd: key numbers
- Share price
- ₹61.37
- Market cap
- ₹85.16 Cr
- Revenue (annual)
- ₹181.7 Cr
- Net profit (annual)
- ₹8.41 Cr
- P/E (TTM)
- 10.7×Sector 46.5×
- Promoter holding
- 38.98%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Denis Chem Lab Ltd
All →Denis Chem Lab Board Meeting Date
Denis Chem Lab Ltd scheduled its board meeting for 4 November 2026 to approve Q1 FY27 unaudited results. Trading window remains closed until 48 hours post-declaration.
Denis Chem Lab Capital Structure Change
VS Holding BV sold 284,447 shares of Denis Chem Lab Ltd via open market transactions. Post-transaction, its shareholding stands at 14.41%.
- Execution
- September and October 2026
Denis Chem Lab Management Change
Denis Chem Lab Limited shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director. His three-year term is effective from August 1, 2026.
- Execution
- 3 years
Denis Chem Lab Other Announcement
Denis Chem Lab Limited's shareholders confirmed the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors. The appointment is for a five-year term ending FY 2030-31.
- Execution
- 5 years
Denis Chem Lab Annual General Meeting
Denis Chem Lab Limited conducted its 45th Annual General Meeting on September 25, 2026. Key businesses transacted included the declaration of a Rs. 2.50 per share dividend and management re-appointments.
Denis Chem Lab Capital Structure Change
VS Holding BV sold 307,594 shares in Denis Chem Lab Ltd, reducing its stake to 16.46%. This disclosure was filed under SEBI SAST regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.